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chemistry. The net result is an ability to control the orientation of a tube shaped microparticle on cell surfaces, thus opening up new design space for the fabrication of novel cellbiomaterial hybrids.
In addition to considering the characteristics and potential of synthetic particles as vehicles for drug delivery, the functionalization of a cell surface with synthetic materials to create cell-biomaterial hybrids is an evolving new method to control cell phenotype, fate and function. [4, 8, 9] A logical extension of this approach is to attach synthetic particles directly to the surface of living cells to enhance their native functionalities and provide additional capabilities not found in nature. [4, 9, 10] Toward this goal, prior work in our group has investigated the attachment of payload carrying cellular backpacks onto immune system cells for cell-mediated drug delivery, imaging and magnetic manipulation. [4, 11] These disc-shaped cellular backpacks, which are microns wide and a few hundred nanometers thick, are able to resist internalization by macrophages due to their unique shape. [4] The ability to attach functional, cargo carrying backpacks onto living immune cells without inducing phagocytosis provides new opportunities for extracellular targeted drug delivery. In this work, we explore the use of hollow microtubes with a controllable, non-uniform presentation of functional groups as a new type of biomaterial with the means to control particle orientation on cell surfaces.
Controlling the orientation of a microparticle on a cell surface requires the use of an anisotropic particle with distinct surface regions that promote and resist cellular attachment.
Surfaces that are highly hydrated are commonly used to resist cell attachment, [12] while surfaces presenting particular ligands promote cell attachment.
[2] Polyelectrolyte multilayers (PEMs) can achieve such surface characteristics simply by choice of polyelectrolytes and assembly conditions. [12, 13] In this work, poly(acrylic acid)/poly(allylamine hydrochloride) (PAA/PAH) multilayers assembled at pH 3 were used to create microtube surfaces that resist cell interactions due to their highly hydrated nature. [12] To create regions of the microtubes Submitted to 3 that strongly interact with the lymphocyte B-cells used in this study, multilayers containing the biopolymers hyaluronic acid (HA) and chitosan (CHI) were used. Previous studies have
shown that the B-cell CD44 receptor binds strongly and specifically to HA present in a film. [13] HA containing multilayers have also been used to interact with other cell types including macrophages and T-cells. [4, 11] Rhodamine (Rhod) labeled PAH and fluorescein (FITC) labeled CHI were used to identify the two different multilayer systems (depicted as red and green colors respectively in all figures).
To fabricate anisotropic, chemically non-uniform microtubes, we used a simple template approach involving the use of a sacrificial track-etched membrane. [14] [15] [16] The PEM assemblies were designated as follows: (poly1/poly2) z , where poly1 and poly2 represent the polymers used to assemble the multilayer and z is the total number of bilayers deposited (1 bilayer = poly1+poly2). The fabrication sequence for microtubes is shown in Figure 1 . To fabricate chemically uniform tubes, the entire membrane, including the pores, was coated conformally with a PEM (Figure 1 step i) . [17] For completely cell-resistant tubes, multilayers of (PAA/PAH-Rhod) were assembled. [12] The coated membrane was then plasma treated to remove the polymer selectively from the top and bottom surfaces of the membrane; previous work has demonstrated that the polymers within the pores are protected from the plasma etching process (Figure 1 step ii). [15] Carbodiimide chemistry was then used to cross-link the PAH amine groups to the PAA carboxylic acid groups to form stable amide bonds. The shown in Figure 3b with larger images and a movie in the supporting information ( Figure S3 and Movie S1). Approximately 50% of the tubes in groups 2 and 3 did not attach after 1-2 hours of agitation and incubation. This time was chosen as the analysis point since longer intervals of agitation and incubation led to increased attachment and the formation of large aggregates, limiting the ability to determine the attachment orientation. Conditions were not optimized to achieve the highest levels of tube attachment; future work focuses on immobilizing cells on a surface to minimize the aggregation potential. Nevertheless, these data clearly show a preference for microtube attachment based on the location of the cell binding (HA/FITC-CHI) multilayers. Figure 3c compares the ratio of tubes end-on to side-on and further supports the notion that the presentation of HA on the ends of the tubes favors end-on cell surface orientation. Some of the side-on orientation observed with the (HA/FITC-CHI) multilayers on the inside of microtubes may simply be due to the cell binding the HA from both ends of the tube at the same time. We are confident that HA is not diffusing through the (PAA/PAH-Rhod) outside multilayer, since previous work has documented the Submitted to effective blocking properties of PAH-containing layers. [19] Regarding the issue of cytotoxicity, Figure 3d shows that the microtubes did not decrease cellular viability.
In conclusion, we have developed a novel and reproducible fabrication method that allows for the presentation of a selected polymer preferentially on the ends of microtubes. Our method provides a general platform that could be expanded to many applications in biomaterials and responsive materials. In particular, we have shown in the present work that by limiting the cell-adhesive polymer to the end of the microtube, we can control the orientation of an anisotropic microtube on cell surfaces. These results point to the possibility of using microtubes as part of a bottom-up cell scaffold in the future. Controlling the interaction points on the microparticle may allow for structures such as linear or branched 'polymerized' chains of cells. In addition, regions of the microtube can be designed to respond to stimuli such as pH, salt or temperature, opening the possibility of stimuli sensitive polymer tubes for drug delivery or controlled assembly. [14, 20] In general, we believe that FITC-chitosan was made from in a 1% aqueous acetic acid-methanol (1:2 v/v) solution of pH 4.5 at room temperature as described [21] . Rhodamine-PAH was synthesized by reaction Submitted to 7 between PAH and NHS-rhodamine in 50mM MES buffer at pH 8 for 2hrs, after the solution was dialyzed into water. Detailed tube fabrication steps are given in supporting information.
Cell Study: CH27 B-cells were grown in RPMI media with 10% fetal calf serum and 1% penicillin/streptomycin. Before incubation with microtubes the cells were washed with Hanks Buffered Salt Solution and resuspended at 10 6 cells/mL in complete media. The tubes and cells were iteratively incubated on a shaker plate for 15 minutes at 100rpm and then incubated for 15 minutes for 1-2 hours before analysis. Confocal images were taken on a Zeiss LSM 510 using a 488nm Argon laser for FITC excitation and a 543nm HeNe laser for rhodamine excitation. The images were visually analyzed to determine the orientation of the microtube.
A minimum of 100 interactions were analyzed per sample. Cell viability was determined by trypan blue staining. HA and CHI solutions had 100mM NaCl added to the solution. All solution pHs were adjusted to pH 3.0 with 1M HCl. Track-etch polycarbonate membranes were immobilized on teflon holders and sequentially dipped in the polymer solutions using a nanoStrata dipping unit. Polymer depositions were done for 10 minutes, followed by three pH3 Milli-Q water rinses: one for 2 minutes and two for 1 minute, while the substrate was rotating at 100rpm.
Both sides of the membrane were exposed to plasma etching simultaneously. 
